Senior Partner, Public Equity
and access,
Anna is a Senior Partner and leads the public investing strategy for the Venture Investments team. She also serves on the Novo Holdings Life Sciences Operating Committee. Anna is based in San Francisco, California. Prior to joining Novo Holdings, Anna was responsible for covering publicly traded biotech companies at Sectoral Asset Management. She began her career in financial advisory working with fund managers and corporate clients in the life sciences industry. Anna earned her Ph.D. and B.Sc. in Biochemistry, both from McGill University. She is a CFA charterholder.
